Skip to main content
Suzannah Bergstein, MD, Resident Physician, Palo Alto, CA

SuzannahBergsteinMD

Resident Physician Palo Alto, CA

Physician

Dr. Bergstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bergstein's full profile

Already have an account?

  • Office

    725 Welch Rd
    Palo Alto, CA 94304
    Phone+1 650-497-8979

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 2024
  • Duke University
    Duke UniversityBA, 2014 - 2018

Awards, Honors, & Recognition

  • STAR Employee Recognition Award Mount Sinai Hospital, 2023
  • Young Investigators Award for the 2023 Crohn’s and Colitis Congress The Crohn’s and Colitis Foundation and the American Gastroenterological Association, 2023
  • Digestive Disease Research Foundation Fellowship Digestive Disease Research Foundation, 2022-2023
  • Join now to see all

Publications & Presentations

Journal Articles

  • Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease  
    Bergstein, S., Spencer, E. A., Dolinger, M., Pittman, N., Kellar, A., Dunkin, D., Dubinsky, M. C.., Inflammatory Bowel Diseases, 12/22/2023
  • Feasibility and Impact of a Quality Improvement Initiative to Screen for Malnutrition in an Inflammatory Bowel Disease Clinic  
    Gold, S. L., Kohler, D., Philippou, A., Rabinowitz, L., Manning, L., Keefer, L., Bergstein, S., Birhanu, B., Raman, M., Dubinsky, M., Sands, B. E., Colombel, J. F., Un..., Clinical Nutrition ESPEN, 12/2022

Abstracts/Posters

  • HLA-DQA1*05 associates with immunogenicity and loss of response to anti-TNF therapy in the IBD population: A meta-analysis. [Oral Presentation]
    Bergstein, S., Spencer, E. A., European Crohn’s and Colitis Organization (ECCO), Copenhagen, DNK, 3/3/2023
  • Single center experience with upadacitinib for refractory pediatric Inflammatory Bowel Disease [Oral Presentation]
    Bergstein, S., Spencer, E. A., Crohn’s and Colitis Congress, Denver, CO, 1/21/2023
  • HLA-DQA1*05 associates with immunogenicity and loss of response to anti-TNF therapy in the IBD population: A meta-analysis
    Bergstein, S., Spencer, E. A., Crohn’s and Colitis Congress, Denver, CO, 1/19/2023
  • Join now to see all